EUVIMEDEUVIMED entdecken
Crossref

Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK/NF-κB pathways and acute lung injury in vivo

Xiaoxiao Pei, Zeyi Zhang, Nina Wang, Guozheng Huang, Xiaoran Min, Yanzi Yang, Jianguo Cao

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Xiaoxiao Pei und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shanghai Normal University, Shanghai 200234, China. Hauptthemen laut MEDLINE: NF-kappa B, Acute Lung Injury. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Anhui University of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a devastating respiratory disorder characterized by rapid alveolar injury, uncontrolled inflammatory response, etc. Onychiol B is a cyathane diterpene originally isolated from fern plants. In this study, onychiol B can inhibit the production and secretion of pro-inflammatory cytokines such as NO, iNOS, IL-6 and TNF-α in LPS-stimulated RAW264.7 cells by restraining the NF-κB and the p38 MAPK pathway. In addition, it prevents the production of ROS and reduces the loss of mitochondrial membrane potential in LPS-stimulated RAW264.7 cells. Furthermore, in the acute lung injury mouse model induced by LPS injected into the trachea, onychiol B alleviates pulmonary edema, reverses inflammatory mediator TNF-α, IL-6, and IL-β secretion in lung. In general, our data show that significant anti-ALI effects of onychiol B would render it a potential candidate for the treatment of inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BAcute Lung InjuryAnimalsMiceLipopolysaccharidesTumor Necrosis Factor-alphaInterleukin-6InflammationCytokinesRAW 264.7 Cells

Stichwörter der Autor:innen

Acute lung injuryInflammationOnychiol BROS

Substanzen

NF-kappa BLipopolysaccharidesTumor Necrosis Factor-alphaInterleukin-6Cytokines

Autor:innen und Institutionen

  • College of Life Sciences, Shanghai Normal University, Shanghai 200234, China.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • College of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan 243002, China.
  • College of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan 243002, China. Electronic address: guozheng.huang@ahut.edu.cn.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: yangyanzi@zcmu.edu.cn.
  • College of Life Sciences, Shanghai Normal University, Shanghai 200234, China. Electronic address: cao101@shnu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Anhui University of Technology

Zitieren

APA

Pei, X., Zhang, Z., Wang, N., Huang, G., Min, X., Yang, Y., & Cao, J. (2023). Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK/NF-κB pathways and acute lung injury in vivo. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106351

Vancouver

Pei X, Zhang Z, Wang N, Huang G, Min X, Yang Y, et al. Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK/NF-κB pathways and acute lung injury in vivo. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106351

BibTeX
@article{Pei2023,
  author = {Pei, Xiaoxiao and Zhang, Zeyi and Wang, Nina and Huang, Guozheng and Min, Xiaoran and Yang, Yanzi and Cao, Jianguo},
  title = {Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK/NF-κB pathways and acute lung injury in vivo},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106351}
}
Kostenlos starten →